|
White Blood Cell Count procedure
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Genetic analyses of diverse populations improves discovery for complex traits.
|
31217584 |
2019 |
|
White Blood Cell Count procedure
|
|
0.800 |
GeneticVariation
|
GWASDB |
Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network.
|
22037903 |
2012 |
|
White Blood Cell Count procedure
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network.
|
22037903 |
2012 |
|
White Blood Cell Count procedure
|
|
0.800 |
GeneticVariation
|
GWASDB |
Genome-wide association study of white blood cell count in 16,388 African Americans: the continental origins and genetic epidemiology network (COGENT).
|
21738479 |
2011 |
|
Blood Protein Measurement
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
|
Interleukin 8 Measurement
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors.
|
27989323 |
2017 |
|
Monocyte count procedure
|
|
0.700 |
GeneticVariation
|
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
|
Blood basophil count (lab test)
|
|
0.700 |
GeneticVariation
|
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
|
Monocyte count result
|
|
0.700 |
GeneticVariation
|
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
|
C-reactive protein measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation.
|
22291609 |
2012 |
|
Polysomnography
|
|
0.700 |
GeneticVariation
|
GWASDB |
Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.
|
23251661 |
2012 |
|
Hepatitis C
|
|
0.030 |
GeneticVariation
|
BEFREE |
In this study, we evaluate the association between the <i>DARC</i> rs12075 polymorphism and liver stiffness progression in HCV-infected patients.
|
30970632 |
2019 |
|
Hepatitis C
|
|
0.030 |
GeneticVariation
|
BEFREE |
Our result indicates that atypical chemokine receptor 1 polymorphism (rs12075) does not affect susceptibility to hepatitis C virus.
|
28443566 |
2017 |
|
Hepatitis C
|
|
0.030 |
GeneticVariation
|
BEFREE |
Although serum CCL2 levels were associated with early liver fibrosis, rs12075 itself was not associated with HCV infection or the severity of liver disease in any of the cohorts.
|
21156192 |
2011 |
|
Fibrosis, Liver
|
|
0.020 |
GeneticVariation
|
BEFREE |
Specifically, patients with the <i>DARC</i> rs12075 AG/GG genotype had a lower risk of liver fibrosis progression and development of cirrhosis.
|
30970632 |
2019 |
|
Secondary malignant neoplasm of lymph node
|
|
0.020 |
GeneticVariation
|
BEFREE |
Our previous research clarified two functional nonsynonymous single nucleotide polymorphisms (SNPs): rs12075 in DARC and rs2228468 in CCBP2 were significantly correlated with lymph node metastasis.
|
30358125 |
2018 |
|
Secondary malignant neoplasm of lymph node
|
|
0.020 |
GeneticVariation
|
BEFREE |
Two non-synonymous SNPs, rs12075 (G42D) in DARC and rs2228468 (S373Y) in CCBP2, were observed to be associated with LNM in univariate analysis and remained significant after adjustment for conventional clinical risk factors, with odds ratios (ORs) of 0.54 (95% confidence interval [CI], 0.37 to 0.79) and 0.78 (95% CI, 0.62 to 0.98), respectively.
|
24260134 |
2013 |
|
Secondary malignant neoplasm of lymph node
|
|
0.020 |
GeneticVariation
|
BEFREE |
Two non-synonymous SNPs, rs12075 (G42D) in DARC and rs2228468 (S373Y) in CCBP2, were observed to be associated with LNM in univariate analysis and remained significant after adjustment for conventional clinical risk factors, with odds ratios (ORs) of 0.54 (95% confidence interval [CI], 0.37 to 0.79) and 0.78 (95% CI, 0.62 to 0.98), respectively.
|
24260134 |
2013 |
|
Fibrosis, Liver
|
|
0.020 |
GeneticVariation
|
BEFREE |
We here tested the hypothesis that this genetic variant (rs12075 A/G) is a risk factor for liver fibrosis in HCV infection.
|
21156192 |
2011 |
|
Malaria
|
|
0.010 |
GeneticVariation
|
BEFREE |
FYB carriage (deduced from DARC G125A) was not associated with the risk of malaria per se but it protected against severe falciparum malaria (P = 0.03), and hospitalization (P = 0.006) due to falciparum malaria.
|
31551092 |
2019 |
|
Pseudohyperkalemia Cardiff
|
|
0.010 |
GeneticVariation
|
BEFREE |
We found an association between the <i>DARC</i> rs12075 single nucleotide polymorphism (SNP) and CHC progression.
|
30970632 |
2019 |
|
Liver Cirrhosis
|
|
0.010 |
GeneticVariation
|
BEFREE |
Specifically, patients with the <i>DARC</i> rs12075 AG/GG genotype had a lower risk of liver fibrosis progression and development of cirrhosis.
|
30970632 |
2019 |
|
Cirrhosis
|
|
0.010 |
GeneticVariation
|
BEFREE |
Specifically, patients with the <i>DARC</i> rs12075 AG/GG genotype had a lower risk of liver fibrosis progression and development of cirrhosis.
|
30970632 |
2019 |
|
Malaria, Falciparum
|
|
0.010 |
GeneticVariation
|
BEFREE |
FYB carriage (deduced from DARC G125A) was not associated with the risk of malaria per se but it protected against severe falciparum malaria (P = 0.03), and hospitalization (P = 0.006) due to falciparum malaria.
|
31551092 |
2019 |
|
Hepatitis C, Chronic
|
|
0.010 |
GeneticVariation
|
BEFREE |
Impact of <i>DARC</i> rs12075 Variants on Liver Fibrosis Progression in Patients with Chronic Hepatitis C: A Retrospective Study.
|
30970632 |
2019 |